[1] Carranza-Lira S, Bustamante-Mendoza J A, Leanos-Miranda A, et al. [Anti-Mullerian hormone serum levels in women with and without uterine fibroids][J]. Ginecol Obstet Mex, 2013, 81(12): 700-705. [2] 肖春花，陆艳萍，熊伟，等. 760名四川省乐至县妇女子宫肌瘤认知度调查[J]. 川北医学院学报，2012，27(02): 183-186. [3] Firouznia K, Ghanaati H, Jalali A H, et al. Uterine artery embolization for treatment of symptomatic fibroids: a review of the evidence[J]. Iran Red Crescent Med J, 2013, 15(12): e16699. [4] 沈杨，许茜，徐洁，等. 子宫肌瘤危险因素的流行病学调查研究[J]. 实用妇产科杂志，2013，29(03): 189-193. [5] Liu J, Keserci B, Yang X, et al. Volume transfer constant (K(trans)) maps from dynamic contrast enhanced MRI as potential guidance for MR-guided high intensity focused ultrasound treatment of hypervascular uterine fibroids[J]. Magn Reson Imaging, 2014, 32(9): 1156-1161. [6] 王玉玲，柳晓春，谢庆煌，等. 雌激素受体、孕激素受体、血管内皮生长因子及其受体在子宫肌瘤中的表达和临床研究[J]. 实用妇产科杂志，2010，26(06): 436-438. [7] Song Y G, Jang H, Park K D, et al. Non spherical polyvinyl alcohol versus gelatin sponge particles for uterine artery embolization for symptomatic fibroids[J]. Minim Invasive Ther Allied Technol, 2013, 22(6): 364-371. [8] Yang Y, Zhang J, Han Z Y, et al. Ultrasound-guided percutaneous microwave ablation for submucosal uterine fibroids[J]. J Minim Invasive Gynecol, 2014, 21(3): 436-441. [9] 陈红菊，尹伶. 子宫肌瘤病因学的研究进展[J]. 实用预防医学，2012，19(06): 959-961.
2015, Vol. 22 
